Is Adult ADHD a Childhood-Onset Neurodevelopmental Disorder? Evidence From a Four-Decade Longitudinal Cohort Study

Is adult ADHD a continuation of the same childhood-onset neurodevelopmental disorder recognized in children? While the DSM-5 classifies ADHD as a neurodevelopmental disorder that begins in childhood, the researchers sought to test this assumption using a prospective longitudinal design, which avoids the biases of retrospective recall and clinical referral.

The study followed 1,037 individuals born in Dunedin, New Zealand, between 1972 and 1973, from birth to age 38. The researchers conducted both 'follow-forward' analyses (tracking children diagnosed with ADHD to see if they met criteria as adults) and 'follow-back' analyses (examining the childhood history of adults who met DSM-5 criteria for ADHD at age 38). They assessed symptoms, neuropsychological performance, polygenic risk scores, and life impairment indicators using data from parents, teachers, and objective testing.

The study revealed a striking lack of overlap between the childhood and adult ADHD groups. Only 5% of children diagnosed with ADHD continued to meet the criteria as adults, and 90% of adults diagnosed with ADHD had no documented history of childhood ADHD. Furthermore, while the childhood-ADHD group showed clear neurocognitive deficits and elevated polygenic risk, the adult-ADHD group did not share these markers. Despite these differences, the adult-ADHD group reported significant life impairment, including substance dependence and difficulties with daily functioning, indicating a clear need for clinical attention, even if the etiology differs from the classic childhood-onset neurodevelopmental model.

These findings challenge the prevailing view that adult ADHD is simply a persistent form of childhood ADHD. If confirmed, this suggests that the current classification system may be conflating two distinct conditions. This distinction is crucial for directing future research into the etiology of adult-onset ADHD and for developing appropriate, evidence-based treatments for adults who suffer from these symptoms.